心玮医疗-B中期报告 2024

INTERIM REPORT2024 2 4 5 19 27 28 29 31 32 34 46 ACGHKACG 3563813 33191901 6609 131 www.heartcare.com.cn 2021820 50191112 97927 H 1831717121716 881 I. 2024128.517.2%3.294.1%202365.2%44.8% 35.6%45.842.1%82.7 31.818NMPANMPA CEFDA10 29NMPAFDACE — Captor®CaptorNMPA202012CaptorCaptorCaptorCE CAPTOR AIS-LVONMPA2022 CaptorNMPA DEB20205DEBDEBNMPANMPA NMPA NMPANMPA NMPA —(AF)NMPA2022 NMPA 2021810 NMPA 2301161021210277232 2,000 A202210102022119202310162022102420231020 II. 2024630 2023630109.617.2%2024630128.5(AIS) 202363029.9202463046.2 202363079.7202463082.3202363072.7%202463064.0% 202363010.720246309.0(i)(ii) 202363069.9202463031.8(i)(ii)(iii) 202363029.8202463027.0 202363041.7202463030.5 20236301.120246300.9 202463020246303.4%20231231 2024630613.320231231622.28.9 2024630945.320231231945.6 20246301.4202363047.2 2024630 20246305% 2024630 2024630341 2021H 2021H 20211112021H202261020245202021H2021H2021101120224112024417 (a) 2021H(i)(ii)(iii) (a)(b)(c) (b) 2021H2021H (c) 2021HH (d) 2021H2021H20211112021H2021H2021H7.5 (e) (A) 2021H(i)6303,000,000H30%2021H(ii)6302021H300,000H 2021H (B) 2021H (f) (i) (ii)2021H (iv)2021H (v)2021H (vi)13.09(2)(a)XIVA (vii)60 (viii)30 (g) 2021HH3,000,000HH9.5%7.7%20241120246302021H2,703,9001,874,0002021H1% 2021H2021H2021H2021HH2021HHH (1)B100%20241231 (2)2023630B22100%20251231 (3)20246718.013.315.37(i)13,300(ii)855,000(i)A100%20241231(ii)20%30%50%202563020266302027630 H20218201,014.82021810 2024630 2024630 2024630 20246302023630 20246302024630 2C.2.120246302 2C.2.12C.2.1 3.212024630 2024630 24102024630 601133.SH2024314600833.SH2024621 202451 6900.HK2024731 2024830 202483020248302024830 13.51B(1) 13.2013.2113.22 2024630XV(i)XV78(ii)352(iii) (1)1,915,6901,915,690H (2)782,908782,908HWisary Limited1,600,792H(3)869,330869,330H697,158697,158H(4)2021H240,00020256302027630(5)2021H150,00020256302027630(6)2021H5,00020251231 2024630XV78352 2024630XV23336 (2)1,915,6901,915,690H (3)869,330869,330H697,158697,158H (4)906,220906,220H (5)Elbrus Investments Pte. Ltd.Elbrus1,627,907HElbrusTemasek Life Sciences Private LimitedTemasek Life Sciences Private LimitedFullerton Management Pte LtdFullertonManagement Pte LtdTemasek Holdings (Private) LimitedTemasek LifeSciences Private LimitedFullerton Management Pte LtdTemasek Holdings (Private) LimitedElbrus1,627,907HAranda Investments Pte. Ltd.140,000HSeletar Investments Pte LtdSeletar Investments Pte LtdTemasek Capital (Private) LimitedTemasek Capital (Private)LimitedAranda Investments Pte. Ltd140,000H (6)LYFE Columbia River LimitedLYFE Columbia152,5992,899,373HLYFE Ohio RiverLimitedLYFE Ohio49,147933,784HRaritan River65,1161,237,210HLYFE Capital Fund III (Dragon), L.P.227,300HLYFE ColumbiaLYFE Ohio LYFE CapitalFund III (Dragon), L.P.LYFE Capital Fund III (Dragon), L.P.LYFE Capital Management LimitedRaritan RiverLimitedRaritan RiverLYFE Capital Management LimitedLYFE Capital Management LimitedLYFE Capital Fund III (Dragon), L.P.LYFE ColumbiaLYFEOhioLYFE Capital Management LimitedLYFE ColumbiaLYFE OhioRaritan River 2024630XV23336 Ernst & Young27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong 28452024630343434 2410 34 2024830 20246 30 20246 30 20246 30 20246 30 20246 30 1. 2016616202012320218203563813 2. 20246303420231231 3. 20231231 16120201202277 20246 30 3. (a)16——16 (b)2020202212 2023202411 (c)77 20246 30 4. 8 5. 5. 6. 20246 30 7. 20246 30 8. 9. 20246302023630 10. 20242023630 20242023630 20246 30 10. 11. 2024630641,00020236306,468,000 20246302023630943,00096,000 12. 20246 30 20246 30 14. 15. 20211112021H2021H2021H20246302,329,0002023630187,00098,10020236305,000 16. 20246 30 17. (a) 18. 20246 30 18. 20246 30 18. 20231231 202463020231231 20246302023630 19. 2024830